[Federal Register Volume 75, Number 102 (Thursday, May 27, 2010)]
[Notices]
[Pages 29769-29770]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-12778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Integrating Patient-Reported Outcomes in Hospice and 
Palliative Care Practices.
    Date: June 1, 2010.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, 6116 Executive Blvd., Room 
8018, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8123, Bethesda, MD 20892, 301-594-1224, 
<a href="/cdn-cgi/l/email-protection#83f0f0b6b0b4f7c3edeaebade4ecf5"><span class="__cf_email__" data-cfemail="13606026202467537d7a7b3d747c65">[email protected]</span></a>.
    This notice is being published less than 30 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Anticancer Agents.
    Date: June 2, 2010.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8018, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Joyce C. Pegues, B.S., B.A., PhD, Scientific 
Review Officer, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-
1286, <a href="/cdn-cgi/l/email-protection#314154564454425b715c50585d1f5f58591f565e47"><span class="__cf_email__" data-cfemail="bcccd9dbc9d9cfd6fcd1ddd5d092d2d5d492dbd3ca">[email protected]</span></a>.
    This notice is being published less than 30 days prior to the 
meeting due to scheduling conflicts.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer

[[Page 29770]]

Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 20, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-12778 Filed 5-26-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>